FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 18
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 

 


Chair
Kenneth R. Morris, Ph.D. 

Expertise:  Pharmaceutical Material Science
Term: 08/01/2004 - 10/31/2008
Professor of Pharmaceutics
College of Pharmacy
University of Hawaii at Hilo
34 Rainbow Drive
Hilo, Hawaii  96720

Designated Federal Officer
LCDR Sohail Mosaddegh, Pharm.D.
Advisors and Consultants Staff 
Center for Drug Evaluation and Research   
Food and Drug Administration, HFD‑021
5630 Fishers Lane, Room 1079
Rockville, Maryland 20857
Phone: (301) 827‑6791     
Fax: (301) 827‑6776
Email: Sohail.Mosaddegh@FDA.HHS.GOV

**Mukul A. Agrawal, Ph.D. PDF
Expertise: Industry Representative
Term:  06/10/2008 – 10/31/2011
Associate Director, Medical Affairs
Roxane Laboratories, Inc.
1900 Arlingate Lane
Columbus, Ohio  43228

Jessie L-S Au, Pharm.D., Ph.D. pdf
Expertise: Biochemistry
Term: 11/01/2006 - 10/31/2010
Distinguished University Professor
The Ohio State University
508 Riffe Building
496 W. 12th Avenue
Columbus, Ohio 43210

John F. Carpenter, Ph.D. pdf
Expertise: Pharmaceutical Biotechnology
Term: 10/06/2006 - 10/31/2010
Professor of Pharmaceutical Biotechnology
Department of Pharmaceutical Sciences
School of Pharmacy, Campus Box C238
University of Colorado Health Sciences Center
4200 E. Ninth Avenue
Denver, Colorado 80262

 Carol A. Gloff, Ph.D. PDF
Expertise:  Pharmaceutical Sciences
Term:  07/11/2005 - 10/31/2008
Carol Gloff & Associates
6 Langdon Road
Natick, Massachusetts 01760

*Merrill Goozner PDF
Expertise: Consumer Representative
Term: 06/30/2008 – 10/30/2011
Director of Integrity and Science Project
Center for Science in the Public Interest
1875 Connecticut Avenue, N.W., Suite 300
Washington, District of Columbia 20009

**Philip R. Mayer, Ph.D. PDF
Expertise: Industry Representative
Term:  06/10/2008 – 10/31/2011
Assistant Vice President, Clinical Pharmacology
Clinical Research and Development
Wyeth Research
P.O.  Box 42528
Philadelphia, Pennsylvania  19101

Marilyn E. Morris, Ph.D. PDF
Expertise: Pharmaceutical/Pharmacokinetics/ Dynamics
Term: 11/01/2006 - 10/31/2009
Professor
Department of Pharmaceutical Sciences
University at Buffalo, State University of New York
School of Pharmacy
527 Hochstetter Hall
Amherst, New York 14260

Anne S. Robinson, Ph.D. pdf
Expertise: Chemical Engineer
Term: 11/01/06 - 10/31/2010
Professor
University of Delaware
Department of Chemical Engineering
Colburn Laboratory, Room 259
150 Academy Street
Newark, Delaware 19716

**Richard J. Stec, Jr., Ph.D. pdf
Expertise: Industry Representative
Term:  06/10/2008 – 10/31/2011 
Vice President, Regulatory Affairs, Americas
Hospira, Inc.
275 North Field Drive
D-389, Building H-2
Lake Forest, Illinois  60045

Elizabeth M. Topp, Ph.D. pdf
Expertise: Chemical Engineer/Pharmaceutics
Term: 10/06/2006 - 10/31/2008
Professor
Department of Pharmaceutical Chemistry
The University of Kansas
2095 Constant Avenue
Lawrence, Kansas 66047

**Patricia C. Tway, Ph.D. pdf
Expertise: Industry Representative
Term:  06/10/2008 – 10/31/2011
Vice President, Regulatory & Analytical Sciences
Merck Manufacturing Division
Merck & Co.
WP82-20
770 Sumneytown Pike
P.O. Box 4
West Point, Pennsylvania  19486


* Consumer Representative
** Industry Representative (non voting)

Adobe Reader PDF requires the free Adobe Acrobat Reader

 arrow Back to Top  arrow Back to Pharmaceutical Science Advisory Committee Info 

  Human Drug Advisory Committee Information

Date created: July 22, 2003, Updated, October 17, 2008

 
horizonal rule